CSX Forecast, price target & analysts
CSX Target price 2025 - Analyst rating & recommendation
CSX Classifications & Recommendation:
CSX Price Target
| Target Price | $40.80 |
| Price | $35.36 |
| Potential | 15.38% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target CSX 2026 . The average CSX target price is $40.80. This is 15.38% higher than the current stock price. The highest price target is $47.25 33.63% , the lowest is $27.27 22.88% . | |
| A rating was issued by 32 analysts: 23 Analysts recommend CSX to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 15.38% . Most analysts recommend the CSX stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2030
27 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.3b . This is 1.43% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $14.9b 5.83% , the lowest is $13.9b 1.81% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $14.5b | 0.80% |
|---|---|---|
| 2025 | $14.3b | 1.48% |
| 2026 | $14.9b | 4.15% |
| 2027 | $15.6b | 4.35% |
| 2028 | $16.2b | 3.93% |
| 2029 | $17.0b | 4.78% |
| 2030 | $17.5b | 3.10% |
26 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $6.6b . This is 2.70% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.1b 9.53% , the lowest is $6.1b 5.08% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $7.0b | 1.02% |
|---|---|---|
| 2025 | $6.6b | 5.01% |
| 2026 | $7.2b | 8.48% |
| 2027 | $7.6b | 5.53% |
| 2028 | $8.0b | 5.23% |
| 2029 | $8.4b | 4.29% |
EBITDA Margin
| 2024 | 48.14% | 0.22% |
|---|---|---|
| 2025 | 46.42% | 3.58% |
| 2026 | 48.34% | 4.14% |
| 2027 | 48.89% | 1.14% |
| 2028 | 49.50% | 1.25% |
| 2029 | 49.27% | 0.46% |
29 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.1b . This is 7.64% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.3b 13.19% , the lowest is $3.0b 3.07% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $3.5b | 5.40% |
|---|---|---|
| 2025 | $3.1b | 9.98% |
| 2026 | $3.6b | 15.02% |
| 2027 | $4.0b | 11.39% |
| 2028 | $4.4b | 9.66% |
| 2029 | $4.8b | 10.29% |
| 2030 | $5.5b | 14.64% |
Net Margin
| 2024 | 23.87% | 4.64% |
|---|---|---|
| 2025 | 21.81% | 8.61% |
| 2026 | 24.08% | 10.41% |
| 2027 | 25.70% | 6.73% |
| 2028 | 27.12% | 5.53% |
| 2029 | 28.55% | 5.27% |
| 2030 | 31.74% | 11.17% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
29 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.68 . This is 8.39% higher than earnings per share in the financial year 2024. The highest EPS forecast is $1.76 13.55% , the lowest is $1.61 3.87% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $1.79 | 1.65% |
|---|---|---|
| 2025 | $1.68 | 6.15% |
| 2026 | $1.93 | 14.88% |
| 2027 | $2.15 | 11.40% |
| 2028 | $2.36 | 9.77% |
| 2029 | $2.60 | 10.17% |
| 2030 | $2.98 | 14.62% |
P/E ratio
| Current | 22.81 | 18.59% |
|---|---|---|
| 2025 | 21.08 | 7.60% |
| 2026 | 18.33 | 13.05% |
| 2027 | 16.45 | 10.26% |
| 2028 | 15.00 | 8.81% |
| 2029 | 13.61 | 9.27% |
| 2030 | 11.87 | 12.78% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 5.89 and an P/S ratio of 4.60 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 5.98 | 2.22% |
|---|---|---|
| 2025 | 5.89 | 1.49% |
| 2026 | 5.66 | 3.99% |
| 2027 | 5.42 | 4.17% |
| 2028 | 5.22 | 3.78% |
| 2029 | 4.98 | 4.56% |
| 2030 | 4.83 | 3.01% |
P/S ratio
| Current | 4.66 | 0.80% |
|---|---|---|
| 2025 | 4.60 | 1.41% |
| 2026 | 4.41 | 3.99% |
| 2027 | 4.23 | 4.17% |
| 2028 | 4.07 | 3.78% |
| 2029 | 3.88 | 4.56% |
| 2030 | 3.77 | 3.01% |
Current CSX Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 20 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 20 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 20 2025 |
| Raymond James |
Outperform
➜
Outperform
|
Unchanged | Oct 17 2025 |
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Oct 17 2025 |
| TD Cowen |
Buy
➜
Buy
|
Unchanged | Oct 17 2025 |
| Jefferies |
Buy
➜
Buy
|
Unchanged | Oct 17 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 20 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 20 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 20 2025 |
|
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Oct 17 2025 |
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Oct 17 2025 |
|
Unchanged
TD Cowen:
Buy
➜
Buy
|
Oct 17 2025 |
|
Unchanged
Jefferies:
Buy
➜
Buy
|
Oct 17 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
